PL5 Endocrine Genetic and Epigenetic Control of Development: Bases for Human Health and Disease

Program: Plenary
Translational Session
Sunday, April 3, 2016: 10:00 AM-11:15 AM
Hall B2 (BCEC)

From oxytocin to dopamine and a handful of hypothalamic peptides: Honoring three Nobel prizes that paved the way to our current understanding of the genetics and environmental disruption of reproduction.

10:00 AM
Lisa H Fish, MD, Hennepin County Medical Ctr, Edina, MN
Nothing to Disclose: LHF
10:15 AM
Barbara A Cohn, PhD, Public Health Institute, Berkeley, CA
Nothing to Disclose: BAC
10:40 AM
William F Crowley Jr., MD, Reproductive Endocrine Unit of the Department of Medicine, Massachusetts General Hospital, Boston, MA
Nothing to Disclose: WFC Jr.
See more of: Plenary

 

The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire